Biotricity (BTCY) Competitors

$0.11 +0.01 (+6.23%)

As of 03:58 PM Eastern

BTCY vs. POAI, OSRH, RVP, ICCM, and ZJYL

Should you buy Biotricity stock or one of its competitors? MarketBeat compares Biotricity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Biotricity include Predictive Oncology (POAI), OSR (OSRH), Retractable Technologies (RVP), IceCure Medical (ICCM), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry.

How does Biotricity compare to Predictive Oncology?

Biotricity (NASDAQ:BTCY) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Biotricity has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Predictive Oncology has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 10.1% of Biotricity shares are owned by company insiders. Comparatively, 1.2% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Biotricity has a net margin of -80.42% compared to Predictive Oncology's net margin of -5,065.23%. Biotricity's return on equity of 0.00% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Predictive Oncology	-5,065.23%	-732.73%	-235.55%

Predictive Oncology has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.26	-$14.09M	-$0.16	N/A
Predictive Oncology	$1.66M	10.46	-$12.66M	-$13.50	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Biotricity and Biotricity both had 1 articles in the media. Biotricity's average media sentiment score of 1.48 beat Predictive Oncology's score of 0.75 indicating that Biotricity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biotricity	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Predictive Oncology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Biotricity beats Predictive Oncology on 8 of the 13 factors compared between the two stocks.

How does Biotricity compare to OSR?

Biotricity (NASDAQ:BTCY) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Comparatively, 60.6% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Biotricity had 1 more articles in the media than OSR. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for OSR. Biotricity's average media sentiment score of 1.48 beat OSR's score of 0.00 indicating that Biotricity is being referred to more favorably in the media.

Company	Overall Sentiment
Biotricity	Positive
OSR	Neutral

Biotricity has higher revenue and earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.26	-$14.09M	-$0.16	N/A
OSR	$2.91M	6.15	-$27.06M	-$0.33	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biotricity has a net margin of -80.42% compared to OSR's net margin of -363.26%. Biotricity's return on equity of 0.00% beat OSR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
OSR	-363.26%	-7.24%	-5.41%

Biotricity has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, OSR has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Summary

Biotricity beats OSR on 9 of the 14 factors compared between the two stocks.

How does Biotricity compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

Retractable Technologies has a net margin of -41.11% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Biotricity	-80.42%	N/A	-188.47%

In the previous week, Retractable Technologies and Retractable Technologies both had 1 articles in the media. Biotricity's average media sentiment score of 1.48 beat Retractable Technologies' score of 0.00 indicating that Biotricity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Biotricity	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Retractable Technologies has higher revenue and earnings than Biotricity. Retractable Technologies is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.54	-$7.01M	-$0.21	N/A
Biotricity	$12.06M	0.26	-$14.09M	-$0.16	N/A

Retractable Technologies has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Biotricity has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market.

Summary

Retractable Technologies beats Biotricity on 7 of the 12 factors compared between the two stocks.

How does Biotricity compare to IceCure Medical?

Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

Biotricity has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.26	-$14.09M	-$0.16	N/A
IceCure Medical	$3.38M	5.67	-$15.06M	-$0.24	N/A

IceCure Medical has a consensus target price of $2.09, suggesting a potential upside of 786.72%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than Biotricity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Biotricity has a net margin of -80.42% compared to IceCure Medical's net margin of -441.60%. Biotricity's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
IceCure Medical	-441.60%	-211.73%	-119.13%

In the previous week, IceCure Medical had 7 more articles in the media than Biotricity. MarketBeat recorded 8 mentions for IceCure Medical and 1 mentions for Biotricity. Biotricity's average media sentiment score of 1.48 beat IceCure Medical's score of -0.51 indicating that Biotricity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biotricity	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IceCure Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Biotricity has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market.

Summary

Biotricity beats IceCure Medical on 10 of the 16 factors compared between the two stocks.

How does Biotricity compare to Jin Medical International?

Biotricity (NASDAQ:BTCY) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

Jin Medical International has higher revenue and earnings than Biotricity.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.26	-$14.09M	-$0.16	N/A
Jin Medical International	$20.69M	0.90	$1.19M	N/A	N/A

Biotricity has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.52, indicating that its share price is 652% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Biotricity's net margin of -80.42%.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Jin Medical International	N/A	N/A	N/A

In the previous week, Biotricity had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for Jin Medical International. Biotricity's average media sentiment score of 1.48 beat Jin Medical International's score of 0.00 indicating that Biotricity is being referred to more favorably in the media.

Company	Overall Sentiment
Biotricity	Positive
Jin Medical International	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

3.9% of Biotricity shares are held by institutional investors. 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Jin Medical International beats Biotricity on 7 of the 11 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BTCY vs. The Competition

Export

Metric	Biotricity	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.12M	$49.65M	$6.34B	$12.29B
Dividend Yield	N/A	1.08%	2.79%	5.33%
P/E Ratio	-0.10	17.49	21.09	25.40
Price / Sales	0.26	34.30	528.21	79.15
Price / Cash	N/A	18.87	44.13	56.13
Price / Book	-0.08	13.38	9.99	7.01
Net Income	-$14.09M	-$17.35M	$3.55B	$335.05M
7 Day Performance	-45.32%	-1.06%	0.42%	-0.29%
1 Month Performance	-51.68%	-14.23%	-0.05%	1.15%
1 Year Performance	-79.00%	-5.65%	35.06%	34.79%

Biotricity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BTCY Biotricity	N/A	$0.11 +6.2%	N/A	-78.1%	$3.12M	$12.06M	N/A	40	News Coverage Positive News Gap Down High Trading Volume
POAI Predictive Oncology	0.2116 of 5 stars	$6.48 -2.7%	N/A	-71.2%	$21.99M	$1.66M	N/A	30	Gap Down
OSRH OSR	0.4179 of 5 stars	$0.60 -2.7%	N/A	-56.5%	$21.65M	$2.91M	N/A	N/A
RVP Retractable Technologies	N/A	$0.69 -1.4%	N/A	-6.6%	$20.66M	$38.27M	N/A	240	News Coverage
ICCM IceCure Medical	2.8144 of 5 stars	$0.24 +1.7%	$2.09 +767.2%	-76.9%	$19.25M	$3.38M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BTCY) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biotricity (BTCY) Competitors

BTCY vs. POAI, OSRH, RVP, ICCM, and ZJYL

How does Biotricity compare to Predictive Oncology?

Summary

How does Biotricity compare to OSR?

Summary

How does Biotricity compare to Retractable Technologies?

Summary

How does Biotricity compare to IceCure Medical?

Summary

How does Biotricity compare to Jin Medical International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biotricity (BTCY) Competitors

BTCY vs. POAI, OSRH, RVP, ICCM, and ZJYL

How does Biotricity compare to Predictive Oncology?

Which has more risk and volatility, BTCY or POAI?

Do institutionals & insiders believe in BTCY or POAI?

Is BTCY or POAI more profitable?

Which has stronger valuation and earnings, BTCY or POAI?

Do analysts prefer BTCY or POAI?

Does the media prefer BTCY or POAI?

Summary

How does Biotricity compare to OSR?

Do institutionals and insiders have more ownership in BTCY or OSRH?

Does the media refer more to BTCY or OSRH?

Which has preferable earnings & valuation, BTCY or OSRH?

Do analysts prefer BTCY or OSRH?

Is BTCY or OSRH more profitable?

Which has more volatility and risk, BTCY or OSRH?

Summary

How does Biotricity compare to Retractable Technologies?

Is RVP or BTCY more profitable?

Does the media favor RVP or BTCY?

Do institutionals & insiders hold more shares of RVP or BTCY?

Which has preferable earnings and valuation, RVP or BTCY?

Which has more volatility & risk, RVP or BTCY?

Summary

How does Biotricity compare to IceCure Medical?

Which has better valuation & earnings, BTCY or ICCM?

Do analysts rate BTCY or ICCM?

Do institutionals & insiders hold more shares of BTCY or ICCM?

Is BTCY or ICCM more profitable?

Does the media refer more to BTCY or ICCM?

Which has more risk & volatility, BTCY or ICCM?

Summary

How does Biotricity compare to Jin Medical International?

Which has higher valuation & earnings, BTCY or ZJYL?

Which has more volatility & risk, BTCY or ZJYL?

Is BTCY or ZJYL more profitable?

Does the media favor BTCY or ZJYL?

Do analysts prefer BTCY or ZJYL?

Do insiders and institutionals have more ownership in BTCY or ZJYL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTCY vs. The Competition

Biotricity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools